Keywords: Sanofi-Aventis, Harvard University, Translational biomedical research, Cancer, Diabetes, Inflammation

Sanofi-Aventis collaborates with Harvard University on translational biomedical research

Article | 19 October 2010

Print This

In a third accord with academia this year, Sanofi-Aventis (Euronext: SAN) this morning announced a research collaboration with the USA& ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in